Scientific Library of Tomsk State University

   E-catalog        

Normal view MARC view

Nitro-imidazoles in ferrocenyl alkylation reaction. Synthesis, enantiomeric resolution and in vitro and in vivo bioeffects L. V. Snegur, M. V. Lyapunova, D. D. Verina [et al.]

Contributor(s): Lyapunova, Maria V | Verina, Daria D | Kachala, Vadim V | Korlyukov, Alexander A | Ilyin, Mikhail M | Davankov, Vadim A | Ostrovskaya, Larissa A | Bluchterova, Natalia V | Fomina, Margarita M | Snegur, Lubov V | Malkov, Victor S | Nevskaya, Kseniya V | Pershina, Alexandra G | Simenel, Alexander AMaterial type: ArticleArticleContent type: Текст Media type: электронный Subject(s): ферроценовые соединения | нитроимидазолыGenre/Form: статьи в журналах Online resources: Click here to access online In: Journal of Organometallic Chemistry Vol. 871. P. 10-20Abstract: Ferrocenylalkyl nitro-imidazoles (4a-h, 5a-h) were prepared via the regiospecific reaction of the α-(hydroxy)alkyl ferrocenes, FcCHR (OH) (1a–h; Fc = ferrocenyl; R = H, Me, Et, Pr, i-Pr, Ph, ortho-Cl-Ph, ortho-I-Ph), with nitro-imidazoles in aqueous organic medium (H2O-CH2Cl2) at room temperature in the presence of HBF4, within several minutes in good yields. X-ray structural data for racemic (R,S)-1-N-(benzyl ferrocenyl)-2-methyl-4-nitroimidazole (5f) were determined. The resulting enantiomers were resolved into enantiomers by analytical HPLC on modified amylose or cellulose chiral stationary phases. The viabilities of 4b, 4d, 5b, 5c in vitro, and in experiments in vivo antitumor effects of 1-N-ferrocenylethyl-4-nitroimidazole (4b) against murine solid tumor system Ca755 carcinoma were evaluated.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Ferrocenylalkyl nitro-imidazoles (4a-h, 5a-h) were prepared via the regiospecific reaction of the α-(hydroxy)alkyl ferrocenes, FcCHR (OH) (1a–h; Fc = ferrocenyl; R = H, Me, Et, Pr, i-Pr, Ph, ortho-Cl-Ph, ortho-I-Ph), with nitro-imidazoles in aqueous organic medium (H2O-CH2Cl2) at room temperature in the presence of HBF4, within several minutes in good yields. X-ray structural data for racemic (R,S)-1-N-(benzyl ferrocenyl)-2-methyl-4-nitroimidazole (5f) were determined. The resulting enantiomers were resolved into enantiomers by analytical HPLC on modified amylose or cellulose chiral stationary phases. The viabilities of 4b, 4d, 5b, 5c in vitro, and in experiments in vivo antitumor effects of 1-N-ferrocenylethyl-4-nitroimidazole (4b) against murine solid tumor system Ca755 carcinoma were evaluated.

There are no comments on this title.

to post a comment.
Share